This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
By Kayum Ahmed, Julia Bleckner, and Kyle Knight In mid-May, the WorldHealth Organization officially declared the “emergency” phase of the COVID-19 pandemic over. As reasonable and evidence-based adjustments to prevent transmission and protect health became the norm, authorities continued to fail on equity.
On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. As a result, it publicly promised that “ while the pandemic continues, Moderna will not enforce our COVID-19 related patents against those making vaccines intended to combat the pandemic.”
By Tara Davis and Nicola Soekoe In January 2021, the Director General of the WorldHealth Organization (WHO) observed that the world was on the brink of a “catastrophic moral failure” if wealthier nations did not ensure the equitable distribution of COVID-19 vaccines. This, critically, could have helped save lives.
This is a massive blind spot, as mental health problems are a growing concern worldwide. The experience of COVID-19 is estimated to have led to a 27.6% Low and middle-income countries (LMICs), home to 80% of people with mental illnesses, should prioritize strengthening their mental health systems.
Now the Ministry of Health has published revised regulations in accordance with Annex M of the Drugs and Cosmetics Rules. Now the Ministry of Health has published revised regulations in accordance with Annex M of the Drugs and Cosmetics Rules. Warning Letter, 19 January 2024 Exactech, Inc. Points to Consider No. Exactech, Inc.
It provides a practical guide for the pharmaceuticalindustry on how to implement PACs within the framework of an effective Pharmaceutical Quality System (PQS) and in alignment with ICH quality guidelines. Recommendations for stability studies.
It provides a practical guide for the pharmaceuticalindustry on how to implement PACs within the framework of an effective Pharmaceutical Quality System (PQS) and in alignment with ICH quality guidelines. Recommendations for stability studies.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content